Search
Filter by Topic
- People (79) Apply People filter
- Reproduction (58) Apply Reproduction filter
- Legal (45) Apply Legal filter
- Publications (42) Apply Publications filter
- Experiments (34) Apply Experiments filter
- Processes (30) Apply Processes filter
- Disorders (25) Apply Disorders filter
- Theories (21) Apply Theories filter
- Ethics (18) Apply Ethics filter
- Organizations (18) Apply Organizations filter
- Technologies (15) Apply Technologies filter
- Outreach (10) Apply Outreach filter
- Organisms (4) Apply Organisms filter
- Reproductive Health Arizona (3) Apply Reproductive Health Arizona filter
- DNA (1) Apply DNA filter
- Places (1) Apply Places filter
- Religion (1) Apply Religion filter
Simon Edward Fisher (1970-)
Simon Edward Fisher studied the genes that control speech and language in England and the Netherlands in the late twentieth and early twenty-first centuries. In 2001, Fisher co-discovered the FOXP2 gene with Cecilia Lai, a gene related to language acquisition in humans and vocalization in other mammals. When damaged, the human version of the gene leads to language disorders that disrupt language and speech skills. Fisher's discovery validated the hypothesis that genes influence language, resulting in further investigations of language disorders and their heritability.
Format: Articles
Subject: People
John Craig Venter (1946- )
John Craig Venter helped map the genomes of humans, fruitflies, and other organisms in the US in the late 1990s and early 2000s, and he helped develop an organism with a synthetic genome. In February 2001, Venter and his team published a human genome sequence after using a technique known as Expressed Sequence Tags, or ESTs. Venter worked to bridge commercial investment with scientific research. Venter founded a number of private companies, including the for-profit Celera Genomics, headquartered in Alameda, California, as well as research institutes, such as the not-for-profit J.
Format: Articles
Subject: People
The US President's Council on Bioethics (2001-2009)
The US President's Council on Bioethics was an organization headquartered in Washington D.C. that was chartered to advise then US President George W. Bush on ethical issues related to biomedical science and technology. In November 2001, US President George W. Bush created the President's Council on Bioethics (PCB). Convened during a nationwide cloning and embryonic stem cell research debate, the Council stated that it worked to address arguments about ethics from many different perspectives.
Format: Articles
Subject: Organizations, Legal, Ethics
George W. Bush Executive Order 13455, June 2007
On 20 January 2001, Republican George W. Bush was sworn in as the forty-third president of the United States, replacing Democrat William J. Clinton. During his eight years in office, Bush issued many executive orders, often altering previous policy. By signing Order 13435 on 22 June 2007, he changed how stem cell research would be performed in America.
Format: Articles
Subject: Legal
Thesis: The Hwang Woo-Suk Scandal and the Development of Bioethics in South Korea
In 2004, the South Korean geneticist Woo-Suk Hwang published what was widely regarded as the most important research finding in biotechnology that year. In the prestigious American journal Science, he claimed that he had succeeded in cloning a human blastocyst, which is an embryo in its early developmental stages (Hwang et al. 2004). A year later, in a second Science article, he made the earth-shattering announcement that he had derived eleven embryonic stem cell lines using his cloning technique (Hwang et al. 2005). The international scientific community was stunned.
Format: Essays and Theses
Barack Obama Executive Order 13505, November 2008
On 20 November 2009 Democrat Barack Obama replaced Republican George W. Bush as president of the United States. Obama soon initiated changes to Bush's 2001 executive order concerning scientific research involving human stem cells. Stem cell research remains a controversial issue in the US. Some individuals consider it immoral to experiment with an embryo because they regard embryos as human beings from the moment of conception, while others believe stem cell research could lead to great scientific advancements.
Format: Articles
Subject: Legal
David Wildt's Evolving Ethics Concerning the Roles of Wildlife Reproductive Sciences in Species Conservation
David Wildt is an animal reproductive biologist who directs the Conservation Biology Institute in Fort Royal, Virginia. In 1986, Wildt argued that artificial reproductive technologies should only be used for species conservation efforts if standard techniques to aid natural reproduction are not effective. Between 1986 and 2001, Wildt revised his views and values primarily in relation to two things: which methods captive breeding programs ought to use, and how reproductive scientists ought to contribute to the larger work of conservation.
Format: Articles
Subject: Ethics
The Human Genome Project (1990-2003)
The Human Genome Project (HGP) was an international scientific effort to sequence the entire human genome, that is, to produce a map of the base pairs of DNA in the human chromosomes, most of which do not vary among individuals. The HGP started in the US in 1990 as a public effort and included scientists and laboratories located in France, Germany, Japan, China, and the United Kingdom.
Format: Articles
Subject: Organizations
NovaSure Endometrial Ablation
NovaSure is a device for endometrial ablation, which is a procedure that removes the endometrium, that the US Food and Drug Administration, or FDA, approved for use on 28 September 2001. Endometrium is the tissue that lines the uterus. NovaSure destroys the endometrium by sending electric beams at the endometrium. Hologic, a medical technology company concerned with women’s health, developed NovaSure to treat menorrhagia, or heavy bleeding during menstruation. Menorrhagia is a common symptom of endometriosis. Endometriosis is the growth of the endometrium outside of the uterus.
Format: Articles
Subject: Technologies
“Miscarriage of Medicine: The Growth of Catholic Hospitals and the Threat to Reproductive Health Care” (2013), by Lois Uttley, Sheila Reynertson, Larraine Kenny, and Louise Melling
In 2013, Lois Uttley, Sheila Reynertson, Larraine Kenny, and Louise Melling published “Miscarriage of Medicine: The Growth of Catholic Hospitals and the Threat to Reproductive Health Care,” in which they analyzed the growth of Catholic hospitals in the United States from 2001 to 2011 and the impact those hospitals had on reproductive health care. In the US, Catholic hospitals are required to abide by the US Catholic Church's Ethical Guidelines for Health Care Providers, also called the Directives.
Format: Articles
Subject: Publications
“Screening for Breast Cancer with Mammography” (2013), by Peter Gøtzsche and Karsten Jørgensen
Screening for Breast Cancer with Mammography is a Cochrane systematic review originally published by Peter Gøtzsche and Karsten Jørgensen in 2001 and updated multiple times by 2013. In the 2013 article, the authors discuss the reliability of the results from different clinical trials involving mammography and provide their conclusions about whether mammography screening is useful in preventing deaths from breast cancer.
Format: Articles
Subject: Publications
City of Akron v. Akron Center for Reproductive Health (1983)
In the 1983 case City of Akron v. Akron Center for Reproductive Health the US Supreme Court ruled that certain requirements of the city of Akron’s “Regulation on Abortion” ordinance violated women’s rights to abortions. Despite the legalization of abortion in the 1973, with the US Supreme Court case Roe v. Wade, individual states passed legislation regulating certain aspects of abortion.
Format: Articles
Subject: Legal
General Embryological Information Service, published annually by the Hubrecht Laboratory, 1949-1981
The General Embryological Information Service (GEIS) was an annual report published by the Hubrecht Laboratory in Utrecht, The Netherlands from 1949 to 1981 that disseminated contemporary research information to developmental biologists. The purpose of the annual report was to catalog the names, addresses, and associated research of every developmental biologist in the world. Pieter Nieuwkoop edited each issue from 1949 until 1964, when Job Faber began assisting Nieuwkoop. Bert Z. Salome joined the editing team in 1968 before Nieuwkoop ceased editing duties in 1971.
Format: Articles
Subject: Organizations
Francis Sellers Collins (1950- )
Francis Sellers Collins helped lead the International Human Genome Sequencing Consortium, which helped describe the DNA sequence of the human genome by 2001, and he helped develop technologies used in molecular genetics while working in the US in the twentieth and twenty-first centuries. He directed the US National Center for Human Genome Research (NCHGR), which became the National Human Genome Research Institute (NHGRI), of the US National Institutes of Health (NIH), located in Bethesda, Maryland, from 1993 to 2008.
Format: Articles
Subject: People
The First Successful Cloning of a Gaur (2000), by Advanced Cell Technology
Advanced Cell Technology (ACT), a stem cell biotechnology company in Worcester, Massachusetts, showed the potential for cloning to contribute to conservation efforts. In 2000 ACT researchers in the United States cloned a gaur (Bos gaurus), an Asian ox with a then declining wild population. The researchers used cryopreserved gaur skin cells combined with an embryo of a domestic cow (Bos taurus). A domestic cow also served as the surrogate for the developing gaur clone.
Format: Articles
Subject: Experiments
NuvaRing
The NuvaRing is a self-administered hormonal contraceptive device in the form of a flexible plastic ring that is inserted into the vagina. It releases the hormones etonogestrel and ethinylestradiol, which are synthetic forms of the female reproductive hormones progesterone and estrogen, respectively. The pharmaceutical company Organon first made NuvaRing in the Netherlands in 1980s. The Netherlands first approved it for use in February of 2001, and the United States did the same in October of that year.
Format: Articles
Subject: Technologies, Reproduction, Legal
Tay-Sachs Disease
In 1881 British opthalmologist Warren Tay made an unusual observation. He reported a cherry-red spot on the retina of a one-year-old patient, a patient who was also showing signs of progressive degeneration of the central nervous system as manifested in the child's physical and mental retardation. This cherry-red spot is a characteristic that would eventually come to be associated with metabolic neurological disorders like Sandhoff, GM-1, Niemann-Pick, and, to the credit of Tay, the lysosomal storage disorder known as Tay-Sachs disease.
Format: Articles
Subject: Disorders
The Singapore Bioethics Advisory Committee
Established in tandem with Singapore's national Biomedical Sciences Initiatives, the Bioethics Advisory Committee (BAC) was established by the Singapore Cabinet in December 2000 to examine the potential ethical, legal, and social issues arising from Singapore's biomedical research sector, and to recommend policy to Singapore's government.
Format: Articles
Subject: Organizations, Ethics, Legal
Brian K. Hall (1941- )
Brian Hall is the son of Doris Garrad and Harry Hall, and was born in Port Kembla, NSW Australia, on 28 October 1941. He attended the University of New England in Armidale NSW, graduating in 1963 with a BSc in zoology, in 1965 with a BSc (Honors) in zoology, and in 1968 with a PhD in zoology. His PhD thesis, undertaken under the supervision of Patrick D. F. Murray, FAA was on the differentiation of bone and secondary cartilage in chicken embryos.
Format: Articles
Subject: People
Ooplasmic Transfer Technology
Ooplasmic transfer, also called cytoplasmic transfer, is an outside the body, in vitro fertilization (IVF) technique. Ooplasmic transfer in humans (Homo sapiens) is similar to in vitro fertilization (IVF), with a few additions. IVF is the process in which doctors manually combine an egg and sperm cells in a laboratory dish, as opposed to artificial insemination, which takes place in the female's body. For ooplasmic transfer, doctors withdraw cytoplasm from a donor's oocyte, and then they inject that cytoplasm with sperm into a patient's oocyte.
Format: Articles
Subject: Technologies
"The Multi-Dimensional Human Embryo"
The Multi-Dimensional Human Embryo website (http://embryo.soad.umich.edu/) is a publicly accessible online database of the first three-dimensional images and animations of human embryos during different stages of development. Both the images and animations were created using magnetic resonance microscopy and compiled for easy access.
Format: Articles
Subject: Outreach, Organizations
Mechanistic Realization of the Turtle Shell
Turtle morphology is unlike that of any other vertebrate. The uniqueness of the turtle's bodyplan is attributed to the manner in which the turtle's ribs are ensnared within its hard upper shell. The exact embryological and genetic mechanisms underpinning this peculiar anatomical structure are still a matter of debate, but biologists agree that the evolution of the turtle shell lies in the embryonic development of the turtle.
Format: Articles
Subject: Processes
Advanced Cell Technology, Inc.
Advanced Cell Technology, Inc. (ACT) is a biotechnology company that uses stem cell technology to develop novel therapies in the field of regenerative medicine. Formed in 1994, ACT grew from a small agricultural cloning research facility located in Worcester, Massachusetts, into a multi-locational corporation involved in using both human embryonic stem cells (hESC) and human adult stem cells as well as animal cells for therapeutic innovations.
Format: Articles
Subject: Organizations, Reproduction
Roman v. Roman (2006)
In the case Randy M. Roman v. Augusta N. Roman (2006), the Court of Appeals of Texas followed courts in other states and upheld the validity and enforceability of in vitro fertilization (IVF) consent agreements. The Romans, a divorced couple, each sought different outcomes for their cryopreserved preembryos created during their marriage. Randy Roman sought to have them destroyed, and Augusta Roman sought to implant them in an attempt to have biological children.
Format: Articles
Subject: Legal
California Proposition 71 (2004)
The California Stem Cell Research and Cures Act, also called Proposition 71, was a ballot
initiative proposed by California voters in 2004 to allocate three billion dollars of state
funds for stem cell research over ten years. Endorsed by California scientists and
patient-advocates, Prop 71 passed on 2 November 2004, amending the state constitution to make
stem cell research a constitutional right. In addition, Prop 71 led to the creation of the
California Institute for Regenerative Medicine (CIRM), in San Francisco, California to allocate
Format: Articles
Subject: Legal